To keep you better informed about the biggest trends and developments affecting medication management, medication adherence, and pharmacy services, here are 10 of the most significant news reports published in the final month of 2021. Highlights include stories on new Joint Commission standards, the challenge of medication costs, pharmacist burnout, chronic disease spending, and heart medications.
MedPage Today discusses the expectation that The Joint Commission will increase medication management standards for hospitals seeking accreditation in 2022.
Millions of adults delayed getting or didn't fill prescription drugs prior to the COVID-19 pandemic due to cost, according to a Modern Healthcare report on the results of a new survey.
McKinsey & Co. examine to shift of pharmacy-care delivery to the home and its implications for stakeholders.
An MDLinx column explains why physicians should consider working more closely with pharmacists, including incorporating pharmacists into integrated teams and leveraging collaborative practice agreements.
The Board of Trustees of the American Pharmacists Association (APhA) has released a statement concerning pharmacist burnout that speaks to its root causes and shares potential solutions.
An Avalere study reveals that personalized, in-home chronic disease management services, including medication management, can have a significant impact on spending for seniors with chronic conditions, reports HealthPayerIntelligence.
AJMC reports on an observational study that shows people aging with HIV experience more drug-drug interactions compared with those without HIV.
A study reveals that adherence to type 2 diabetes medications did not significantly change from 2017 to 2019, according to an Endocrine Today report.
A poster presentation at "The Liver Meeting Digital Experience" reveals that for patients with hepatitis C, integration of clinical pharmacists along with universal testing can improve access to direct-acting antiviral therapy and help patients achieve sustained virologic response, reports Healio.
Research reveals that more frequent prescribing of generic medications for heart and blood vessel diseases in Medicare's prescription drug program could save hundreds of millions of dollars, reports Medical Xpress.